Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blann

Showing results (291-300 of 420) with videos related to

Pageof 42
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2005
The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular diseaseH S Lim, A Y Chong, B Freestone, et al.
Annals of Medicine|May 21, 2005
Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markersKiat T Tan, Muzahir H Tayebjee, Cheryl Lynd, et al.
Thrombosis Research|August 27, 2005
Platelet activation in pregnancy-induced hypertensionIoannis Karalis, Sunil K Nadar, Eman Al Yemeni, et al.
Diabetes Care|November 25, 2004
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial interventionHoong Sern Lim, Andrew D Blann, Aun Yeong Chong, et al.
Annals of Medicine|October 16, 2007
Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levelsRumi J Jaumdally, Chetan Varma, Andrew D Blann, et al.
Chest|October 3, 2007
Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplastyRumi J Jaumdally, Chetan Varma, Andrew D Blann, et al.
International Journal of Cardiology|September 18, 2015
Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort studyAndrew D Blann, Amitava Banerjee, Deirdre A Lane, et al.
Thrombosis and Haemostasis|December 21, 2005
Plasma markers of angiogenesis in pregnancy induced hypertensionSunil K Nadar, Ioannis Karalis, Eman Al Yemeni, et al.
The American Journal of Cardiology|January 7, 1998
Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophyG Y Lip, A D Blann, A F Jones, et al.
Arthritis and Rheumatism|January 1, 2000
Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trialM Dziadzio, C P Denton, R Smith, et al.
Pageof 42

Showing results (291-300 of 420) with videos related to

Sort By:
Pageof 42
Diabetic Medicine : a Journal of the British Diabetic Association|February 19, 2005
The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular diseaseH S Lim, A Y Chong, B Freestone, et al.
Annals of Medicine|May 21, 2005
Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markersKiat T Tan, Muzahir H Tayebjee, Cheryl Lynd, et al.
Thrombosis Research|August 27, 2005
Platelet activation in pregnancy-induced hypertensionIoannis Karalis, Sunil K Nadar, Eman Al Yemeni, et al.
Diabetes Care|November 25, 2004
Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial interventionHoong Sern Lim, Andrew D Blann, Aun Yeong Chong, et al.
Annals of Medicine|October 16, 2007
Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: differences in central versus peripheral levelsRumi J Jaumdally, Chetan Varma, Andrew D Blann, et al.
Chest|October 3, 2007
Platelet activation in coronary artery disease: intracardiac vs peripheral venous levels and the effects of angioplastyRumi J Jaumdally, Chetan Varma, Andrew D Blann, et al.
International Journal of Cardiology|September 18, 2015
Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort studyAndrew D Blann, Amitava Banerjee, Deirdre A Lane, et al.
Thrombosis and Haemostasis|December 21, 2005
Plasma markers of angiogenesis in pregnancy induced hypertensionSunil K Nadar, Ioannis Karalis, Eman Al Yemeni, et al.
The American Journal of Cardiology|January 7, 1998
Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophyG Y Lip, A D Blann, A F Jones, et al.
Arthritis and Rheumatism|January 1, 2000
Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trialM Dziadzio, C P Denton, R Smith, et al.
Pageof 42